Introduction of a Smartphone Based Behavioral Intervention for Migraine in the Emergency Department

Overview

Journal Gen Hosp Psychiatry

Specialties Health Services
Psychiatry

Date 2021 Jan 23

PMID 33485090

Citations 6

Authors

Mia T Minen

Benjamin W Friedman

Samrachana Adhikari

Sarah Corner

Scott W Powers

Elizabeth K Seng

Corita Grudzen

Richard B Lipton

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether a smartphone application (app) with an electronic headache diary and a progressive muscle relaxation (PMR) intervention is feasible and acceptable to people presenting to the Emergency Department (ED) with migraine.

Methods: This single arm prospective study assessed feasibility by actual use of the app and acceptability by satisfaction with the app. We report preliminary data on change in migraine disability and headache days.

Results: The 51 participants completed PMR sessions on a mean of 13 ± 19 (0,82) days for the 90-day study period, lasting a median of 11 min (IQR 6.5, 17) each. Median number of days of diary use was 34 (IQR 10, 77). Diaries were completed at least twice a week in half of study weeks (337/663). Participants were likely (≥4/5 on a 5-point Likert scale) to recommend both the app (85%) and PMR (91%). MIDAS scores significantly decreased by a mean of 38 points/participant (p < 0.0001). More frequent PMR use was associated with a higher odds of headache free days (p = 0.0148).

Conclusion: Smartphone-based PMR introduced to patients who present to the ED for migraine is feasible and acceptable. More frequent users have more headache free days. Future work should focus on intervention engagement.

Citing Articles

Implementing a digital solution for patients with migraine-Developing a methodology for comparing digitally delivered treatment with conventional treatment: A study protocol.

Niiberg-Pikksoot T, Laas K, Aluoja A, Braschinsky M PLOS Digit Health. 2024; 3(2):e0000295.

PMID: 38421955 PMC: 10903846. DOI: 10.1371/journal.pdig.0000295.

Headache providers' perspectives of headache diaries in the era of increasing technology use: a qualitative study.

Minen M, George A, Lebowitz N, Katara A, Snyder I Front Neurol. 2024; 14:1270555.

PMID: 38322798 PMC: 10844531. DOI: 10.3389/fneur.2023.1270555.

Feasibility and Usability of a Mobile App-Based Interactive Care Plan for Migraine in a Community Neurology Practice: Development and Pilot Implementation Study.

Young N, Ridgeway J, Haddad T, Harper S, Philpot L, Christopherson L JMIR Form Res. 2023; 7:e48372.

PMID: 37796560 PMC: 10587810. DOI: 10.2196/48372.

Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era.

Chen X, Luo Y J Pain Res. 2023; 16:111-117.

PMID: 36660558 PMC: 9842514. DOI: 10.2147/JPR.S387548.

Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM).

Oliveira Goncalves A, Laumeier I, Hofacker M, Raffaelli B, Burow P, Dahlem M Front Neurol. 2022; 13:912288.

PMID: 35785344 PMC: 9243352. DOI: 10.3389/fneur.2022.912288.

References

Daly E, Donn P, Galliher M, Zimmerman J . Biofeedback applications to migraine and tension headaches: a double-blinded outcome study. Biofeedback Self Regul. 1983; 8(1):135-52. DOI: 10.1007/BF01000544. View

Lipton R, Lombard L, Ruff D, Krege J, Shen Loo L, Buchanan A . Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study. J Headache Pain. 2020; 21(1):20. PMC: 7041198. DOI: 10.1186/s10194-020-01088-4. View

Jette N, Patten S, Williams J, Becker W, Wiebe S . Comorbidity of migraine and psychiatric disorders--a national population-based study. Headache. 2007; 48(4):501-16. DOI: 10.1111/j.1526-4610.2007.00993.x. View

Friedman B, Solorzano C, Esses D, Xia S, Hochberg M, Dua N . Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan. Ann Emerg Med. 2010; 56(1):7-17. PMC: 2902611. DOI: 10.1016/j.annemergmed.2010.02.005. View

Hawkins K, Wang S, Rupnow M . Direct cost burden among insured US employees with migraine. Headache. 2007; 48(4):553-63. DOI: 10.1111/j.1526-4610.2007.00990.x. View

Insinga R, Ng-Mak D, Hanson M . Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. Cephalalgia. 2011; 31(15):1570-5. DOI: 10.1177/0333102411425960. View

Minen M, Adhikari S, Seng E, Berk T, Jinich S, Powers S . Smartphone-based migraine behavioral therapy: a single-arm study with assessment of mental health predictors. NPJ Digit Med. 2019; 2:46. PMC: 6550263. DOI: 10.1038/s41746-019-0116-y. View

Leon A, Davis L, Kraemer H . The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2010; 45(5):626-9. PMC: 3081994. DOI: 10.1016/j.jpsychires.2010.10.008. View

Lipton R, Bigal M, Diamond M, Freitag F, Reed M, Stewart W . Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68(5):343-9. DOI: 10.1212/01.wnl.0000252808.97649.21. View

10.

Minen M, Begasse de Dhaem O, Kroon Van Diest A, Powers S, Schwedt T, Lipton R . Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016; 87(7):741-9. DOI: 10.1136/jnnp-2015-312233. View

11.

Stewart W, Lipton R, Whyte J, Dowson A, Kolodner K, Liberman J . An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999; 53(5):988-94. DOI: 10.1212/wnl.53.5.988. View

12.

Minen M, Adhikari S, Padikkala J, Tasneem S, Bagheri A, Goldberg E . Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial. Headache. 2020; 60(10):2232-2246. PMC: 8721526. DOI: 10.1111/head.14010. View

13.

Usmani S, Balcer L, Galetta S, Minen M . Feasibility of Smartphone-Delivered Progressive Muscle Relaxation in Persistent Post-Traumatic Headache Patients. J Neurotrauma. 2020; 38(1):94-101. PMC: 7864112. DOI: 10.1089/neu.2019.6601. View

14.

. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

15.

Burch R, Buse D, Lipton R . Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019; 37(4):631-649. DOI: 10.1016/j.ncl.2019.06.001. View

16.

Minen M, Jalloh A, Ortega E, Powers S, Sevick M, Lipton R . User Design and Experience Preferences in a Novel Smartphone Application for Migraine Management: A Think Aloud Study of the RELAXaHEAD Application. Pain Med. 2018; 20(2):369-377. PMC: 6374137. DOI: 10.1093/pm/pny080. View

17.

Friedman B, Garber L, Yoon A, Solorzano C, Wollowitz A, Esses D . Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014; 82(11):976-83. DOI: 10.1212/WNL.0000000000000223. View

18.

Greenwood M, Hakim A, Carson E, Doyle D . Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis. Rheumatology (Oxford). 2005; 45(1):66-71. DOI: 10.1093/rheumatology/kei100. View

19.

Friedman B, Solorzano C, Norton J, Adewumni V, Campbell C, Esses D . A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department. Acad Emerg Med. 2012; 19(10):1151-7. PMC: 3473153. DOI: 10.1111/j.1553-2712.2012.01458.x. View

20.

Janssen K, Neutgens J . Autogenic training and progressive relaxation in the treatment of three kinds of headache. Behav Res Ther. 1986; 24(2):199-208. DOI: 10.1016/0005-7967(86)90091-4. View